Healius (ASX:HLS)
ASX announcement history & article coverage
Transparent by design.
Announcments by Healius (ASX:HLS) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Ceasing to be a substantial holder
Becoming a substantial holder
Ceasing to be a substantial holder
Change of Director's Interest Notice - Paul Anderson
Becoming a substantial holder
Notification of cessation of securities - HLS
Healius transitions pathology arrangements with Ramsay
Healius secures national pathology agreement with Ramsay Health Care subsidiaries worth $45 million annually
Change in substantial holding
Change in substantial holding
Change in substantial holding
Ceasing to be a substantial holder from MQG
Becoming a substantial holder from MQG
Ceasing to be a substantial holder from MQG
Becoming a substantial holder from MQG
Ceasing to be a substantial holder from MQG
Change in substantial holding
Change in substantial holding
Ceasing to be a substantial holder
Becoming a substantial holder
FY26 trading update and strategic review of assets
Healius updates FY 2026 outlook, plans Agilex Biolabs sale amid rising pathology costs and no Federal funding
Change in substantial holding
Change of Director's Interest Notice - Kathy Ostin
Application for quotation of securities - HLS
Ceasing to be a substantial holder
Becoming a substantial holder from MQG